Rachele Norfolk

Rachele S. Norfolk focuses on complex pharmaceutical litigation; this has included the defense of an international pharmaceutical company in multidistrict litigation and statewide coordinated proceedings. In that role, Rachele has had primary drafting responsibility for various court submissions, including dispositive motions and motions to compel.

She has also taken the lead in responding to written discovery and has assisted with the factual development of the “company case.” Rachele has also assisted in the preparation of a corporate designee sitting for the first deposition in a major pharmaceutical MDL.

In addition to her work in large-scale, consolidated pharmaceutical cases, Rachele has defended clients in individual cases pending in state and federal courts. Rachele’s work on those cases included drafting motions and jury instructions.

In 2015, Rachele was a summer associate with another law firm in Baltimore, where she performed legal research related to products liability and corporate and securities cases, drafted legal memoranda on the “new evidence” standard under FRCP 59, analyzed discovery materials, summarized medical records and depositions, reviewed a bankruptcy plan of reorganization and compiled plan administrator duties, and gathered information on the enforceability of electronic signatures under the E-Sign Act.

Education :

• J.D. summa cum laude University of Baltimore School of Law 2017
• B.S. Paralegal Studiessumma cum laude Stevenson University 2014

Bar Admissions : Maryland

Court Admissions : U.S. District Court for the District of Maryland